Century Therapeutics, Inc. ( IPSC) - Stock Earnings
IPSC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
IPSC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.2 million USD | — USD |
| 2026Q1 | -21.6 million USD | — USD |
| 2026Q2 | -34.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IPSC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -136.7 million USD | 2.2 million USD |
| 2024 | -126.6 million USD | 6.6 million USD |
| 2025 | -9.6 million USD | 109.2 million USD |
| 2026 Est. | — | — |
IPSC
Price: $1.37
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 69234
Market Capitalization: 271.6 million